Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer

Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer

Submitted by admin on January 20, 2023 - 10:46am
Source: 
Endpoints
News Tags: 
Disc Mdedicine
Mabwell Therapeutics
monoclonal antibodies
Headline: 
Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer
snippet: 

Hematology-focused Disc Medicine has agreed to pay a $10 million down payment to Mabwell Therapeutics to develop and commercialize a portfolio of monoclonal antibodies for blood disorders.

Do Not Allow Advertisers to Use My Personal information